Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults.

RBD-specific antibodies are most reliably detected post-infection, independent of the number/severity of symptoms, and correlate with neutralising antibodies at least for six months. They thus qualify best for large-scale seroepidemiological evaluation of both antibody reactivity and virus neutralisation.